News Amgen Reports the MHRA’s Approval of Tepezza to Treat Thyroid Eye DiseaseByRidhi RastogiMay 8, 20250Comments
News China’s NMPA Grants Full Approval to Everest Medicines’ Nefecon for the Treatment of Primary IgAN in Adults at Risk of Disease ProgressionByRidhi RastogiMay 8, 20250Comments
News AstraZeneca’s Calquence (Acalabrutinib) Plus Chemoimmunotherapy Secures the EC’s Approval for 1L Mantle Cell Lymphoma (MCL)ByRidhi RastogiMay 8, 20250Comments
News ViVerita Therapeutics Collaborates with Boehringer Ingelheim to Accelerate Discovery of Novel Therapeutic Targets in OncologyByRidhi RastogiMay 8, 20250Comments
News Johnson & Johnson Reports the EC’s Approval of Subcutaneous & Intravenous Tremfya for Active Crohn’s DiseaseByRidhi RastogiMay 7, 20250Comments
THOUGHTSPOT Take Home Technology to Help You Self-Manage Your HealthcareByPam BrownMay 7, 20250Comments
News Gilead Reports Final P-III (MYR301) Trial Data of Bulevirtide for Patients Living with Chronic Hepatitis Delta VirusByRidhi RastogiMay 7, 20250Comments
News Daiichi Sankyo and AstraZeneca Report Topline P-III (DESTINY-Breast11) Trial Data of Neoadjuvant Enhertu for HER2+ Early-Stage Breast CancerByRidhi RastogiMay 7, 20250Comments
